{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T03:24:59Z","timestamp":1791084299957,"version":"4.1.0"},"reference-count":44,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T00:00:00Z","timestamp":1737331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Bioeng. Biotechnol."],"abstract":"<jats:p>Bioprocessing has been transitioning from batch to continuous processes. As a result, a considerable amount of resource was dedicated to optimising strategies for continuous production. However, the focus has been on developing a suitable and scalable perfusion strategy with little attention given to the selection of optimal cell clones. Cell line development and lead clone selection are critical to bioprocess development. The screening and selection process is typically performed in stages. Microwell plates (MWP) are used to narrow down the number of clone candidates, which will undergo further selective screening in progressively larger small-scale bioreactors (12\u00a0mL\u20133\u00a0L) to identify the top clone for GMP production. Perfusion mode is typically applied at bench-scale for optimisation purposes, while process development and cell clone screening studies at mL-scale still commonly use fed-batch methods. The change of operation mode from bolus feeding to perfusion with a regular exchange of medium, leads to questions regarding the reliability and fit of initial clone selection. Is the early-stage clone ranking impacted by the discrepancy in the operation mode, and does this potentially result in the exclusion of cell clones suitable for perfusion processes? To address this question, we evaluated various CHO cell clones expressing two antibody products using MWP methodologies in fed-batch and semi-perfusion mode. We assessed growth, metabolic, and productivity performance, and ranked cell clones using two different strategies. The first strategy evaluated clones based on a single parameter: the cell-specific productivity (q<jats:sub>P<\/jats:sub>). The second considered a collection of multiple parameters using the metric of the Manufacturability index (MI<jats:sub>CL<\/jats:sub>). Both ranking strategies showed an impact of operation mode and perfusion rate on the clone ranking. Notably, depending on the chosen operation mode, different sets of candidate clones might have been selected for further, more extensive screening. Additionally, we evaluated the reproducibility of our results demonstrating consistency in cell clone growth performance and ranking.<\/jats:p>","DOI":"10.3389\/fbioe.2024.1479633","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:19:55Z","timestamp":1737357595000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Cell clone selection\u2014impact of operation modes and medium exchange strategies on clone ranking"],"prefix":"10.3389","volume":"12","author":[{"given":"Marie","family":"Dorn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ferng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerensa","family":"Klottrup-Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Micheletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/bp990124j","article-title":"Improvement of CHO cell culture medium formulation: simultaneous substitution of glucose and glutamine","volume":"16","author":"Altamirano","year":"2000","journal-title":"Biotechnol. Prog."},{"key":"B2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.jbiotec.2004.02.004","article-title":"Strategies for fed-batch cultivation of t-PA producing CHO cells: substitution of glucose and glutamine and rational design of culture medium","volume":"110","author":"Altamirano","year":"2004","journal-title":"J. Biotechnol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"e1800061","DOI":"10.1002\/biot.201800061","article-title":"Implementation of fully integrated continuous antibody processing: effects on productivity and COGm","volume":"14","author":"Arnold","year":"2019","journal-title":"Biotechnol. J."},{"key":"B4","doi-asserted-by":"publisher","first-page":"e2790","DOI":"10.1002\/btpr.2790","article-title":"Semi-continuous scale-down models for clone and operating parameter screening in perfusion bioreactors","volume":"35","author":"Bielser","year":"2019","journal-title":"Biotechnol. Prog."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1016\/j.biotechadv.2018.04.011","article-title":"Perfusion mammalian cell culture for recombinant protein manufacturing\u2014a critical review","volume":"36","author":"Bielser","year":"2018","journal-title":"Biotechnol. Adv."},{"key":"B6","first-page":"34","article-title":"FDA perspective on continuous manufacturing","volume-title":"IFPAC Annual Meeting","author":"Chatterjee","year":"2012"},{"key":"B7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.coche.2018.10.006","article-title":"Upstream process intensification and continuous manufacturing","volume":"22","author":"Chen","year":"2018","journal-title":"Curr. Opin. Chem. Eng."},{"key":"B8","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/978-3-319-10320-4_13","article-title":"Perfusion processes","volume-title":"Animal cell culture","author":"Chotteau","year":"2015"},{"key":"B9","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1002\/btpr.1703","article-title":"Very high density of Chinese hamster ovary cells in perfusion by alternating tangential flow or tangential flow filtration in WAVE Bioreactor-part II: applications for antibody production and cryopreservation","volume":"29","author":"Clincke","year":"","journal-title":"Biotechnol. Prog."},{"key":"B10","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1002\/btpr.1704","article-title":"Very high density of CHO cells in perfusion by ATF or TFF in WAVE bioreactor. Part I. Effect of the cell density on the process","volume":"29","author":"Clincke","year":"","journal-title":"Biotechnol. Prog."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1002\/bit.27690","article-title":"A common framework for integrated and continuous biomanufacturing","volume":"118","author":"Coffman","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"B12","doi-asserted-by":"publisher","first-page":"3287","DOI":"10.1002\/bit.27670","article-title":"Pilot-scale demonstration of an end-to-end integrated and continuous biomanufacturing process","volume":"118","author":"Coolbaugh","year":"2021","journal-title":"Biotechnol. Bioeng."},{"key":"B13","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/bit.22269","article-title":"Expression of anti-apoptosis genes alters lactate metabolism of Chinese Hamster Ovary cells in culture","volume":"103","author":"Dorai","year":"2009","journal-title":"Biotechnol. Bioeng."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1002\/bit.28682","article-title":"Platform development for high-throughput optimization of perfusion processes\u2014Part I: implementation of cell bleeds in microwell plates","volume":"121","author":"Dorn","year":"","journal-title":"Biotechnol. Bioeng."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/bit.28685","article-title":"Platform development for high-throughput optimization of perfusion processes\u2014Part II: variation of perfusion rate strategies in microwell plates","volume":"121","author":"Dorn","year":"","journal-title":"Biotechnol. Bioeng."},{"key":"B16","doi-asserted-by":"publisher","first-page":"e2811","DOI":"10.1002\/btpr.2811","article-title":"Development of a novel, high-throughput screening tool for efficient perfusion-based cell culture process development","volume":"35","author":"Gagliardi","year":"2019","journal-title":"Biotechnol. Prog."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1160223","DOI":"10.3389\/fbioe.2023.1160223","article-title":"Next-generation cell line selection methodology leveraging data lakes, natural language generation and advanced data analytics","volume":"11","author":"Goldrick","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1002\/btpr.2418","article-title":"Analysis of Tubespins as a suitable scale-down model of bioreactors for high cell density CHO cell culture","volume":"33","author":"Gomez","year":"2017","journal-title":"Biotechnol. Prog."},{"key":"B19","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10529-020-03026-5","article-title":"Establishment and optimization of a high-throughput mimic perfusion model in ambr\u00ae 15","volume":"43","author":"Jin","year":"2021","journal-title":"Biotechnol. Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s10529-023-03346-2","article-title":"Long term culturing of CHO cells: phenotypic drift and quality attributes of the expressed monoclonal antibody","volume":"45","author":"Kaur","year":"2023","journal-title":"Biotechnol. Lett."},{"key":"B21","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1021\/bp9602360","article-title":"Effects of ammonium and lactate on growth and metabolism of a recombinant Chinese hamster ovary cell culture","volume":"13","author":"Lao","year":"1997","journal-title":"Biotechnol. Prog."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1002\/bit.24389","article-title":"Feeding lactate for CHO cell culture processes: impact on culture metabolism and performance","volume":"109","author":"Li","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"B23","doi-asserted-by":"publisher","first-page":"100705","DOI":"10.1016\/j.coche.2021.100705","article-title":"Bioprocess systems analysis, modeling, estimation, and control","volume":"33","author":"Luo","year":"2021","journal-title":"Curr. Opin. Chem. Eng."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e2760","DOI":"10.1002\/btpr.2760","article-title":"Automated and enhanced clone screening using a fully automated microtiter plate\u2010based system for suspension cell culture","volume":"35","author":"Markert","year":"2019","journal-title":"Biotechnol. Prog."},{"key":"B25","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ymben.2011.12.006","article-title":"On metabolic shift to lactate consumption in fed-batch culture of mammalian cells","volume":"14","author":"Mulukutla","year":"2012","journal-title":"Metab. Eng."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e3459","DOI":"10.1002\/btpr.3459","article-title":"GMP implementation of a hybrid continuous manufacturing process for a recombinant non-mAb protein\u2014a case study","volume":"40","author":"Natarajan","year":"2024","journal-title":"Biotechnol. Prog."},{"key":"B27","doi-asserted-by":"publisher","first-page":"e1700499","DOI":"10.1002\/biot.201700499","article-title":"Impact of CHO metabolism on cell growth and protein production: an overview of toxic and inhibiting metabolites and nutrients","volume":"13","author":"Pereira","year":"2018","journal-title":"Biotechnol. J."},{"key":"B28","doi-asserted-by":"publisher","first-page":"107799","DOI":"10.1016\/j.bej.2020.107799","article-title":"New insights into genetic instability of an industrial CHO cell line by orthogonal omics","volume":"164","author":"Qian","year":"2020","journal-title":"Biochem. Eng. J."},{"key":"B29","doi-asserted-by":"publisher","first-page":"108873","DOI":"10.1016\/j.bej.2023.108873","article-title":"Maximizing yield of perfusion cell culture processes: evaluation and scale-up of continuous bleed recycling","volume":"193","author":"Romann","year":"2023","journal-title":"Biochem. Eng. J."},{"key":"B30","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/btpr.2186","article-title":"Screening and assessment of performance and molecule quality attributes of industrial cell lines across different fed-batch systems","volume":"32","author":"Rouiller","year":"2016","journal-title":"Biotechnol. Prog."},{"key":"B31","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jbiotec.2019.12.017","article-title":"Small-scale bioreactor supports high density HEK293 cell perfusion culture for the production of recombinant Erythropoietin","volume":"309","author":"Schwarz","year":"2020","journal-title":"J. Biotechnol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1038\/s41587-022-01630-6","article-title":"Fresh from the biotech pipeline: fewer approvals, but biologics gain share","volume":"41","author":"Senior","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10529-009-0124-0","article-title":"Fed-batch operation of an industrial cell culture process in shaken microwells","volume":"32","author":"Silk","year":"2010","journal-title":"Biotechnol. Lett."},{"key":"B34","unstructured":"High-intensity perfusion CHO medium\n          \n          \n          2024"},{"key":"B36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.cherd.2023.04.066","article-title":"Design and characterization of a novel perfusion reactor for biopharmaceuticals production","volume":"194","author":"Tregidgo","year":"","journal-title":"Chemi. Engineer. Res. Desi."},{"key":"B45","doi-asserted-by":"publisher","first-page":"108906","DOI":"10.1016\/j.bej.2023.108906","article-title":"Development of mL-scale Pseudo-Perfusion methodologies for high-throughput early phase development studies","volume":"195","author":"Tregidgo","year":"","journal-title":"Biochem. Engineer. J."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1038\/nbt.4305","article-title":"Biopharmaceutical benchmarks 2018","volume":"36","author":"Walsh","year":"2018","journal-title":"Nat. Biotechnol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1038\/s41587-022-01582-x","article-title":"Biopharmaceutical benchmarks 2022","volume":"40","author":"Walsh","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1700733","DOI":"10.1002\/biot.201700733","article-title":"Perfusion cell culture decreases process and product heterogeneity in a head-to-head comparison with fed-batch","volume":"14","author":"Walther","year":"2019","journal-title":"Biotechnol. J."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/btpr.2721","article-title":"High-throughput screening of antibody-expressing CHO clones using an automated shaken deep-well system","volume":"34","author":"Wang","year":"2018","journal-title":"Biotechnol. Prog."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3018","DOI":"10.1002\/bit.24584","article-title":"Integrated continuous production of recombinant therapeutic proteins","volume":"109","author":"Warikoo","year":"2012","journal-title":"Biotechnol. Bioeng."},{"key":"B42","doi-asserted-by":"publisher","first-page":"2703","DOI":"10.1002\/bit.26804","article-title":"Development of a shake tube-based scale-down model for perfusion cultures","volume":"115","author":"Wolf","year":"2018","journal-title":"Biotechnol. Bioeng."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1002\/bit.26999","article-title":"Process design and development of a mammalian cell perfusion culture in shake-tube and benchtop bioreactors","volume":"116","author":"Wolf","year":"2019","journal-title":"Biotechnol. Bioeng."},{"key":"B44","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1007\/s00253-022-12342-x","article-title":"Progress in fed-batch culture for recombinant protein production in CHO cells","volume":"107","author":"Xu","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."}],"container-title":["Frontiers in Bioengineering and Biotechnology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1479633\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T07:20:00Z","timestamp":1737357600000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fbioe.2024.1479633\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,20]]},"references-count":44,"alternative-id":["10.3389\/fbioe.2024.1479633"],"URL":"https:\/\/doi.org\/10.3389\/fbioe.2024.1479633","relation":{},"ISSN":["2296-4185"],"issn-type":[{"value":"2296-4185","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,20]]},"article-number":"1479633"}}